Annaida Technologies
How to finance laboratory equipment?
Save capital for milestones?
Made possible by Würth Leasing.

The Company
Nuclear magnetic resonance (NMR) spectroscopy reveals which molecules are present in a sample. Annaida Technologies develops microchip-based sensors that are used in conjunction with an NMR spectrometer. This makes it possible to measure the metabolic chemistry of individual cells and embryos without damaging the sample. Two areas of application: reproductive medicine, where embryos will in the future be assessed without invasive procedures, and life sciences research.
An EPFL spin-off based in the Lausanne Innovation Park, with nine employees. On the advisory board: Kurt Wüthrich, Nobel Prize winner in Chemistry for NMR spectroscopy. The core patent has been granted in the EU, Japan, China, the U.S., and Israel. In April 2025, Annaida completed a Pre-Series A funding round, followed in June 2026 by certification of its quality management system under ISO 13485, the standard for medical device manufacturers.
Anyone conducting measurements on a micro scale needs reference values from a top-of-the-line instrument. That is why the first major laboratory purchase was scheduled for 2025: a 400-MHz NMR spectrometer.
The Starting Point
For a company with nine employees, this isn’t the kind of investment you make on the side. Annaida makes targeted investments in research and development, because the company’s progress is measured by its technical milestones. That’s where the funds should be put to work.
A direct purchase would have tied up capital all at once—capital that could have been put to better use in development. There was no time pressure, no delivery date, and no deadline. It was all about allocating the funds properly.
The central question
How can a state-of-the-art device be brought into the lab without tying up the funds needed for research and the next milestones?
The Solution from Würth Leasing
Würth Leasing financed the spectrometer with a loan of CHF 250,000 over a 48-month term.
CHF 250,000
Investment Volume
48 months
Duration
The offer was preceded by a thorough review. Würth Leasing took a detailed look at Annaida’s business model and development goals and then submitted an offer tailored to the needs of a research-driven company.

Three points were crucial to the solution:
Understanding the business model:
The assessment took into account the development stage and the goals of a research-driven company.
Liquidity remains within the company
Instead of a one-time payment of CHF 250,000, predictable installments over 48 months. The available funds remained in the development budget.
Short decision-making processes
Short response times between calls, with the same contact persons throughout.
The result
The spectrometer became operational, and the funds remained fully available for development. Annaida met the project goals on schedule and made faster progress toward the technical milestones.
| Liquidity | CHF 250,000 is not tied up all at once, but spread out over 48 months |
| Pace of development | Project Goals Achieved on Schedule |
| Financing | Milestones achieved unlocked additional funding |
| Features | 400-MHz NMR spectrometer in our own laboratory |
| Predictability | Fixed payments over 48 months |
The Collaboration
Only a few months passed between the initial meeting and the finalization of the financing.

“Würth Leasing guided us through the entire process: professionally, with dedication, and with a genuinely personal touch. They understood the specific requirements of our situation and worked closely with us to find the right solution. We would recommend Würth Leasing to other companies without hesitation.”
Marco Grisi, CEO and Founder, Annaida Technologies SA
Are you facing a similar situation?
Whether it’s your first major laboratory purchase, an upgrade to your equipment, or growth during a capital-intensive phase: Our leasing specialists will work with you to develop a customized solution—personally, independently, and as equals.